Clinical Research Directory
Browse clinical research sites, groups, and studies.
Novel Therapy Target in Metastatic Prostate Cancer
Sponsor: Fudan University
Summary
The aim of this study is to use multiomics sequencing to explore the molecular characteristics of metastatic prostate cancer (mPCa), especially metastatic castration-resistant prostate cancer (mCRPC). At the same time, mCRPC models will be constructed, including organoids and animal models, serving as a basic and translational research platform to help identify novel drug targets for mPCa.
Official title: Combining Multi-omics Analysis and Organoid Models to Search for Novel Therapy Target in Metastatic Prostate Cancer
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2023-08-01
Completion Date
2028-12-01
Last Updated
2025-06-05
Healthy Volunteers
No
Conditions
Interventions
Tissue
Tissue will be derived from patients during a standard of care procedure
Locations (1)
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China